Hospital News
Return to Redefining Male Infertility Overview
More on Redefining Male Infertility
- All You Need to Know to Conquer Infertility
- Male Infertility Patients Are 20 Times More Likely to Have Testicular Cancer, According to New NewYork-Presbyterian/Weill Cornell Study
- Most Common Cause of Male Infertility Runs in the Family, Study Finds
- New Microsurgical Treatment for Varicocele May Prevent Infertility in Adulthood
- New Technique for Vasectomy Reversal Developed at New York-Cornell
- NewYork-Presbyterian/Weill Cornell Research Brings New Insights, Hope for the Treatment of Male Infertility
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at 2007 American Urological Association Meeting in Anaheim
- New York-Presbyterian Weill Cornell Pioneers New Surgical Technique To Prevent Unnecessary Removal of Testes
- Physician-Scientists Seek Solutions to Reproductive Problems Related to Chromosomal Variations
- Scientific Evidence Points to Male Biological Clock
- The Latest About Male Infertility and Testosterone from NewYork-Presbyterian/Weill Cornell
- Weill Cornell Medical College Researchers Elucidate Molecular Mechanisms of Sperm Maturation and Fertilization
Research and Clinical Trials
Return to Redefining Male Infertility Overview
More on Redefining Male Infertility
Clinical Services
Return to Redefining Male Infertility Overview
More on Redefining Male Infertility
Redefining Male Infertility
New York-Cornell Physicians Report Healthy Deliveries in Partners of Men With a Severe Genetic Disorder
NEW YORK (Mar 16, 1998)
For the first time, couples with a male partner who has been diagnosed with Klinefelter's Syndrome, a genetic disorder that causes sterility in men, have achieved healthy pregnancies and deliveries. Physicians from The Center for Reproductive Medicine and Infertility and the Department of Urology at The New York Hospital-Cornell Medical Center reported their results in the February 26th issue of The New England Journal of Medicine.
"Genetic abnormalities are major causes of azoospermia, an absence of sperm in the semen," said Dr. Zev Rosenwaks, senior author and Director of the Center. "These patients presented a particularly difficult challenge for our IVF team since they were diagnosed with the most complete form of Klinefelter's and did not have sperm in their ejaculate."
In both reported cases, testicular biopsies, where sperm is extracted from the testes, were used to obtain sufficient sperm for in vitro fertilization using Intracytoplasmic Sperm Injection (ICSI), where a single sperm is injected directly into the egg. This resulted in successful pregnancies, and ultimately, the delivery of three healthy infants.
Klinefelter's Syndrome is a genetic disorder characterized by an extra X chromosome which affects nearly 1 in 500 men.
"Our study suggests that ICSI, along with IVF, is an effective treatment for the most complicated cases of male-factor infertility. As long as we can locate some sperm cells, we should be able to continue to expand the application of ICSI," said Dr. Gianpiero Palermo, lead author and Associate Professor of Embryology in Obstetrics and Gynecology.
"ICSI continues to redefine the limits of male sterility. As we continue to make advancements with this technique, it becomes possible for any man who has even a single or few sperm in the testes to achieve fertilization and produce healthy offspring," said Dr. Rosenwaks.
New York-Cornell's Center for Reproductive Medicine and Infertility, one of the largest infertility centers worldwide, treats over 2,000 patients annually, and has achieved a better than 40 percent delivery rate with the application of ICSI. In female partners who are younger than 35 years of age, ICSI can achieve a delivery rate exceeding 50 percent per egg retrieval.
